NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-026-2016-0-PCT-03 Compounds for Improving MRNA Splicing PCT PCT PCT/US2016/013553 Expired
NCI E-122-2015-1-PCT-02 Virus-like Particles With Efficient Epitope Display PCT PCT PCT/DK2016/050011 Expired
NCATS E-026-2016-0-EP-01 Compounds for Improving MRNA Splicing EP DIV 22178466.3 Abandoned
NHGRI E-275-2015-1-US-01 Gene Therapy For Combined Methylmalonic Acidemia/Aciduria and Hyperhomocysteinemia/Homocystinuria, Cobalamin C Type, and Deficiency of MMACHC US 62/279,285 Abandoned
NCATS E-026-2016-0-BR-18 Compounds for Improving MRNA Splicing BR National Stage BR112017015019-0 Pending
NCATS E-026-2016-0-ZA-11 Compounds for Improving MRNA Splicing ZA National Stage 2017/04699 Pending
NCATS E-026-2016-0-MX-01 Compounds for Improving MRNA Splicing MX DIV MX/a/2022/015737 Pending
NCATS E-026-2016-0-MX-08 Compounds for Improving MRNA Splicing MX National Stage MX/a/2017/009295 Pending
NCI E-495-2013-0-US-08 Anti-Human Papillomavirus 16 E6 T Cell Receptors US National Stage 14/905,108 9822162 Issued PDF
NCI E-494-2013-0-US-09 Methods Of Preparing Anti-Human Papillomavirus Antigen T Cells US National Stage 14/905,138 Abandoned
NCI E-065-2016-1-US-01 Combination of Histone Deactylase Inhibitor and Immunotherapy US 62/278,852 Abandoned
NCI E-148-2011-0-US-10 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use of Same For The Treatment Of Cancer US DIV 14/994,403 9624306 Issued PDF
NIAAA E-316-2013-0-CN-07 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate CN National Stage 201480022083.2 Pending
NHLBI E-102-2015-0-US-01 Polyproline Peptides and Methods of Their Use US 62/278,098 Abandoned
NCI E-482-2013-0-US-05 Photoactivable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery US National Stage 14/904,385 10117942 Issued PDF
NCI E-275-2014-0-CA-04 Furoquinolinedione As Inhibitors Of TDP2 CA National Stage 2973484 Issued
NCI E-275-2014-0-CN-11 Furoquinolinedione As Inhibitors Of TDP2 CN DIV 202110013140.2 Issued
NCI E-275-2014-0-CN-07 Furoquinolinedione As Inhibitors Of TDP2 CN National Stage 201680014742.7 Issued
NCI E-275-2014-0-AU-03 Furoquinolinedione As Inhibitors Of TDP2 AU National Stage 2016205137 Issued
NCI E-275-2014-0-DE-08 Furoquinolinedione As Inhibitors Of TDP2 DE EP 16703001.4 Issued
NCI E-275-2014-0-FR-09 Furoquinolinedione As Inhibitors Of TDP2 FR EP 16703001.4 Issued
NCI E-275-2014-0-EP-05 Furoquinolinedione As Inhibitors Of TDP2 EP National Stage 16703001.4 Issued
NCI E-275-2014-0-GB-10 Furoquinolinedione As Inhibitors Of TDP2 GB EP 16703001.4 Issued
NCI E-121-2013-0-US-04 Method for the Diagnosis and Prognosis of Cancer US National Stage 14/903,706 10393745 Issued PDF
NCI E-119-2013-0-US-03 Method for Synthesizing Selectively Labeled RNA US National Stage 14/903,738 10190143 Issued PDF
NCI E-767-2013-0-US-07 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules US National Stage 14/903,659 10053514 Issued PDF
NCI E-275-2014-0-PCT-02 Furoquinolinedione As Inhibitors Of TDP2 PCT PCT PCT/US2016/012672 Expired
NIDCR E-186-2009-0-US-03 Apototic Cell-mediated Induction Of Antigen-specific Regulatory T Cells For The Therapy of Automimmune Diseases in Animals and Humans US National Stage 14/904,054 Pending
NCI E-278-2014-0-PCT-02 Treatment Methods Using Peptide-Based Inhibitors of the STAT3-IL10 Pathway PCT PCT PCT/US2016/012493 Expired
NINDS E-101-2012-1-MX-15 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS MX National Stage MX/a/2016/000219 Pending
NCI E-053-2015-1-DE-07 MYC G-Quadruplex Stabilizing Small Molecules and Their Use DE EP 16709158.6 Issued
NCI E-053-2015-1-FR-08 MYC G-Quadruplex Stabilizing Small Molecules and Their Use FR EP 16709158.6 Issued
NCI E-053-2015-1-GB-09 MYC G-Quadruplex Stabilizing Small Molecules and Their Use GB EP 16709158.6 Issued
NCI E-053-2015-1-CH-06 MYC G-Quadruplex Stabilizing Small Molecules and Their Use CH EP 16709158.6 Issued
NCI E-053-2015-1-EP-03 MYC G-Quadruplex Stabilizing Small Molecules and Their Use EP EP 16709158.6 Issued
NCI E-053-2015-1-PCT-01 MYC G-Quadruplex Stabilizing Small Molecules and Their Use PCT PCT COMB PCT/US2016/012222 Expired
NCI E-065-2016-0-US-01 Combination Of Histone Deacetylase Inhibitor and Immunotherapy US 62/274,946 Abandoned
NINDS E-101-2012-1-NZ-16 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS NZ National Stage 715721 Abandoned
NCATS E-243-2017-0-US-01 USE OF LOW DOSE EMETINE FOR INHIBITION OF HUMAN CYTOMEGALOVIRUS (HCMV) US 62/274,609 Abandoned
NIAID E-060-2015-0-IN-06 Novel Multivalent Nanoparticle-Based Vaccines IN National Stage 201717026077 Issued
NIAID E-060-2015-0-JP-18 Novel Multivalent Nanoparticle-Based Vaccines JP DIV 2021-164905 Issued
NIAID E-060-2015-0-JP-15 Novel Multivalent Nanoparticle-Based Vaccines JP DIV 2019-206110 Issued
NIAID E-066-2013-0-CN-04 Vaccine Comprising AMA1 And RON2 CN National Stage 201480037643.1 Issued
NIAID E-060-2015-0-AU-08 Novel Multivalent Nanoparticle-Based Vaccines AU National Stage 2015373928 Issued
NIAID E-060-2015-0-PCT-02 Novel Multivalent Nanoparticle-Based Vaccines PCT PCT PCT/US2015/068272 Expired
NIAID E-060-2015-0-CN-04 Novel Multivalent Nanoparticle-Based Vaccines CN National Stage 201580076324.6 Pending
NIAID E-060-2015-0-EP-05 Novel Multivalent Nanoparticle-Based Vaccines EP National Stage 15825772.5 Pending
CC E-041-2016-0-US-01 Robot For Prostate Focal Laser Ablation Cancer Treatment Under Magnetic Resonance Imaging Guidance US 62/273,674 Abandoned
NIAID E-060-2015-0-CA-03 Novel Multivalent Nanoparticle-Based Vaccines CA National Stage 2974346 Pending
NIAID E-060-2015-0-BR-09 Novel Multivalent Nanoparticle-Based Vaccines BR National Stage BR112017014219-8 Pending